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Background: Preventive therapies such as tamoxifen are a risk reduction option for women at 
increased risk of breast cancer. Uptake of preventive therapies is low. The Self-Regulatory 
Framework identifies the role of beliefs about medication and its impact on treatment decision-
making. We examined whether women at increased risk of breast cancer can be categorised into 
groups with similar medication beliefs and whether belief group membership was prospectively 
associated with uptake of preventive therapy. 
Methods: Women (n =732) attending an appointment at one of 20 centres in England to discuss 
breast cancer risk were approached; 55.7% (408/732) completed a survey containing the Beliefs 
about Medicines Questionnaire (BMQ) and the Perceived Sensitivity to Medicines (PSM) 
questionnaire. Self-reported uptake of tamoxifen at 3-month follow-up was reported in 258 (63.2%). 
The optimal number of medication belief groups were identified using Latent Profile Analysis (LPA).  
Results: Uptake of tamoxifen was 14.7% (38/258). The LPA model fit statistics supported a 2-group 
model. Both groups held weak beliefs about their need for tamoxifen for current and future health. 
Group 2 (38% of the sample) reported stronger concerns about tamoxifen and medicines in general, 
and stronger perceived sensitivity to the negative effects of medicines compared with Group 1 
(62%). In a multivariable model, women classified into Group 2 (low need, higher concerns) were 
more likely to be: aged ≥50 years (vs. 36–49 years), OR=0.56, 95% CI: 0.34–0.93, p=.024). Women 
with low necessity and lower concerns (Group 1) were more likely to initiate tamoxifen (18.3%; 33) 
than those with low necessity and higher concerns (Group 2) (6.4%; 5). After adjusting for 
demographic and clinical factors, the OR was 3.37 (95% CI: 1.08 – 10.51, p = .036). 
Conclusions and implications: In this UK multi-centre study, uptake of breast cancer preventive 
therapy was low. An important subgroup of women reported low need for preventive therapy and 
strong medication concerns. These women were less likely to initiate tamoxifen. Understanding 
subgroup differences in medication beliefs may enable the development of personalised 
interventional approaches for supporting informed treatment decision-making.  
 
 
